Prognostic Implications of MicroRNA-21 Overexpression in Invasive Ductal Carcinomas of the Breast

被引:71
作者
Lee, Jung Ah [1 ]
Lee, Hye Yoon [1 ]
Lee, Eun Sook [2 ]
Kim, Insun [3 ]
Bae, Jeoung Won [1 ]
机构
[1] Korea Univ, Coll Med, Dept Surg, Seoul 136705, South Korea
[2] Res Inst & Hosp, Ctr Breast Canc, Natl Canc Ctr, Goyang, South Korea
[3] Korea Univ, Coll Med, Dept Pathol, Seoul 136705, South Korea
关键词
Breast neoplasms; Human MicroRNA-21; Oncogene; Prognosis; Survival; PROGESTERONE-RECEPTOR; CANCER; EXPRESSION; MIR-21; SIGNATURES; ESTROGEN; TARGETS; PDCD4;
D O I
10.4048/jbc.2011.14.4.269
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Purpose: Among more than 500 microRNAs, microRNA-21 (miR-21) is known to act as an oncogene. The aim of this study was to investigate the significance of miR-21 expression level in relation with clinicopathological factors and prognosis in breast cancer. Methods: MicroRNA was extracted from cancer and normal breast tissue of 109 breast cancer patients who underwent surgery from 2002 to 2004 using the Taqman (R) MicroRNA Assay. The correlation between miR-21 expression and clinicopathologic features was analyzed and the significance of miR-21 as a prognostic factor and its relationship with survival was determined. Results: MiR-21 expression was higher in cancer tissues than in normal tissues (p<0.0001). High miR-21 expression was associated with mastectomy, larger tumor size, higher stage, higher grade, estrogen receptor (ER) negative, human epidermal growth factor receptor 2 (HER2) positive, HER2 positive breast cancer subtype, high Ki-67 expression, and death. On multivariate analysis, prognostic factors for overall survival were ER and miR-21. High miR-21 expression was significantly related to lower overall survival (p=0.031). Conclusion: This study supports the role of miR-21 as an oncogene and a biomarker for breast cancer with its high expression in cancer tissues and its relationship with other prognostic factors and survival.
引用
收藏
页码:269 / 275
页数:7
相关论文
共 29 条
[1]
The place of chemotherapy in the treatment of early breast cancer [J].
Buzdar, A .
BRITISH JOURNAL OF CANCER, 1998, 78 (Suppl 4) :16-20
[2]
MicroRNA signatures in human cancers [J].
Calin, George A. ;
Croce, Carlo M. .
NATURE REVIEWS CANCER, 2006, 6 (11) :857-866
[3]
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study [J].
Carey, Lisa A. ;
Perou, Charles M. ;
Livasy, Chad A. ;
Dressler, Lynn G. ;
Cowan, David ;
Conway, Kathleen ;
Karaca, Gamze ;
Troester, Melissa A. ;
Tse, Chiu Kit ;
Edmiston, Sharon ;
Deming, Sandra L. ;
Geradts, Joseph ;
Cheang, Maggie C. U. ;
Nielsen, Torsten O. ;
Moorman, Patricia G. ;
Earp, H. Shelton ;
Millikan, Robert C. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (21) :2492-2502
[4]
Evaluation and validation of total RNA extraction methods for MicroRNA expression analyses in formalin-fixed, paraffin-embedded tissues [J].
Doleshal, Martina ;
Magotra, Amber A. ;
Choudhury, Bhavna ;
Cannon, Brian D. ;
Labourier, Emmanuel ;
Szafranska, Anna E. .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (03) :203-211
[5]
Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the arimidex, tamoxifen, alone or in combination trial [J].
Dowsett, Mitch ;
Allred, Craig ;
Knox, Jill ;
Quinn, Emma ;
Salter, Janine ;
Wale, Chris ;
Cuzick, Jack ;
Houghton, Joan ;
Williams, Norman ;
Mallon, Elizabeth ;
Bishop, Hugh ;
Ellis, Ian ;
Larsimont, Denis ;
Sasano, Hironobu ;
Carder, Pauline ;
Cussac, Antonio Llombart ;
Knox, Fiona ;
Speirs, Valerie ;
Forbes, John ;
Buzdar, Aman .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (07) :1059-1065
[6]
Edge SB., 2010, AJCC cancer staging manual, V7th, P347
[7]
RNA expression analysis from formalin fixed paraffin embedded tissues [J].
Farragher, Susan M. ;
Tanney, Austin ;
Kennedy, Richard D. ;
Harkin, D. Paul .
HISTOCHEMISTRY AND CELL BIOLOGY, 2008, 130 (03) :435-445
[8]
Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells [J].
Frankel, Lisa B. ;
Christoffersen, Nanna R. ;
Jacobsen, Anders ;
Lindow, Morten ;
Krogh, Anders ;
Lund, Anders H. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (02) :1026-1033
[9]
Reliable microRNA profiling in routinely processed formalin-fixed paraffin-embedded breast cancer specimens using fluorescence labelled bead technology [J].
Hasemeier, Britta ;
Christgen, Matthias ;
Kreipe, Hans ;
Lehmann, Ulrich .
BMC BIOTECHNOLOGY, 2008, 8 (1)
[10]
MicroRNAs as Novel Biomarkers for Breast Cancer [J].
Heneghan, H. M. ;
Miller, N. ;
Lowery, A. J. ;
Sweeney, K. J. ;
Kerin, M. J. .
JOURNAL OF ONCOLOGY, 2010, 2010